A Study to Identify Risk Factors from any Reason for Hospital Readmission, Death, or Declining Health in Older Persons who were Hospitalized with a Heart Attack

Overview

About this study

The purpose of this study is to gather data to develop a risk model that can be used to help doctors predict the recovery of older persons who have been admitted to the hospital with a heart attack. Information will be collected on hospital readmissions, death, and decline in health from any cause following a heart attack. The goal is help older people in the future make well-informed decisions about their health care during a heart attack.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age ≥75 years upon admission to the hospital
Elevation of cardiac markers within 24 hours of presentation to the hospital
- Troponin must rise above the upper limit of normal established by the hospital as a determinate of cardiac injury
Any one of the following
- Symptoms of ischemia
- ECG with ischemic changes
- Imaging evidence of Infarction
- Intracoronary thrombus on angiography

Exclusion Criteria:

Patient transferred from another hospital with a length of stay >48 hours at the referring hospital
Refused Informed Consent
Decisional impairment with no legally authorized representative
AMI is secondary to chest trauma
AMI is secondary to in-patient procedure or surgery
History of heart transplant
Non-English/Non-Spanish speaking
Inability to complete interview (e.g. comatose or aphasia)
Inability to contact for follow-up (e.g. no access to phone, not living in the country)
Currently a prisoner
Death prior to enrollment
Previously enrolled in SILVER-AMI
Troponin elevation is the result of apical ballooning syndrome (i.e., Takotsubo)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Patricia Best, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Patricia Best, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials